Preemptive Rituximab Treatment May Reduce the Incidence of Post-Transplant Lymphoproliferative Disorders (PTLD) In Patients with EBV Reactivation after Allogeneic Stem Cell Transplantation

✍ Scribed by T.L. Kindwall-Keller; B.W. Cooper; M.J. Laughlin; S.L. Gerson; P. Barr; S. Erinc; R.J. Creger; H.M. Lazarus

• Book ID: 116280785
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 56 KB
• Volume: 15
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2008.12.282